PMA device
Prolieve Thermodilatation System
Medifocus, Inc. · System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ, Class III) · First FDA decision Feb 19, 2004, newest Nov 20, 2007Enlarged prostate (BPH)
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
1
Naming "Prolieve Thermodilatation"
MAUDE reports
0
Brand "Prolieve Thermodilatation", since 2015
PubMed studies
2
Mentioning "Prolieve Thermodilatation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prolieve Thermodilatation System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- PROLIEVE THERMODILATATION SYSTEMPMA supplement
P030006-S013 · Decided Nov 20, 2007 · 211 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- PROLIEVE THERMODILATATION SYSTEMPMA supplement
P030006-S010 · Decided Jan 20, 2006 · 50 days after receipt · Normal 180 Day Track No User Fee
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
- PROLIEVE THERMODILATATION SYSTEMPMA supplement
P030006-S009 · Decided Mar 15, 2006 · 114 days after receipt · Normal 180 Day Track
Device type: System, hyperthermia, rf/microwave (benign prostatic hyperplasia),thermotherapy (MEQ) · GI, Urology & Nephrology
3 more FDA decisions with a free account
Older decisions: P030006-S001, P030006
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prolieve Thermodilatation", any status and sponsor, newest update first.
- Transurethral Thermodilatation vs. Prostatic Urethral Lift for Moderate-to-Severe BPHPivotal-lookingRecruiting
The University of Hong KongAcademic, hospital or other
NCT07759752 · 150 participants (planned) · Start Aug 6, 2026 · Primary completion Aug 5, 2029
Device: Prolieve Transurethral Thermodilatation System; UroLift Prostatic Urethral Lift System · For: BPH (Benign Prostatic Hyperplasia); LUTS(Lower Urinary Tract Symptoms)
Sites: Hong Kong, Hong Kong
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prolieve Thermodilatation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MEQ
3 reports: 1 malfunction, 2 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1692-2009 · Started Jul 20, 2009 · Posted by FDA Jul 28, 2009
Reason given: Balloon leaks: Boston Scientific has received complaints from the field involving product leaks associated with the anchor balloons and compression balloons. Correspondence between BSC and FDA has led to BSC's decision to remove the Prolieve Catheter Kits from the field.
Cause as FDA categorized it: Process design · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
Z-1248-06 · Started May 4, 2006 · Posted by FDA Jul 19, 2006
Reason given: A medical device accessory used by healthcare practitioners in the invasive treatment of (BPH) benign prostatic hyperplasia may be defective. The catheter may fail to achieve or maintain recommended pressure.
Cause as FDA categorized it: Other · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
Z-0843-06 · Started Mar 22, 2006 · Posted by FDA May 6, 2006
Reason given: Surgical treatment kits containing medical device components were mislabeled with extended expiration dates.
Cause as FDA categorized it: Other · Device type: System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy (MEQ)
1 more recall records with a free account
Published research
The most relevant PubMed records for "Prolieve Thermodilatation"[tiab]. The summary above synthesizes these.
- A controlled, randomized, head-to-head comparison of the Prolieve thermodilatation System versus the Targis System for benign prostatic hyperplasia: safety, procedural tolerability, and clinical results.
Shore ND, Sethi PS · J Endourol · 2010Comparative Study, Multicenter Study
- Interstitial temperature mapping during Prolieve transurethral microwave treatment: imaging reveals thermotherapy temperatures resulting in tissue necrosis and patent prostatic urethra.
Larson BT, Robertson DW, Huidobro C, et al. · Urology · 2006Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code MEQ.
- Urologix Targis SystemUrologix, LLC · PMA 2015
- TMX-2000 BphBoston Scientific Corp · PMA 2004
- Prostalund Coretherm System and Prostaland Coretherm AccessoriesProstalund AB · PMA 2014
- Prolieve Thermodilitation SystemMedifocus, Inc. · PMA 2011
- Coretherm System Microwave ThermotherapyProstalund AB · PMA 2009
- ProstatronUrologix, Inc. · PMA 2005
- Prolieve Thermodilation SystemMedifocus, Inc. · PMA 2018
- Urologix Prostatron SystemUrologix, Inc. · PMA 2008
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.